Ilan Y, Shouval D
Department of Medicine A, Hadassah University Hospital, Jerusalem, Israel.
Isr J Med Sci. 1992 Oct;28(10):683-7.
Primary biliary cirrhosis (PBC) is a relatively rare autoimmune disorder leading to the destruction of the interlobular biliary epithelium, which has not been reported in the Middle East. We studied 30 patients with PBC who had been referred to the Liver Unit at the Hadassah Medical Center in Jerusalem. The diagnosis was established by conventional criteria in 28 female and 2 male patients. Twenty-two patients were of Ashkenazic origin and 8 of Sephardic background. Mean serum alkaline phosphatase activity at the time of diagnosis was 911 IU/l gamma-glutamyl transpeptidase 677 u/l, cholesterol 73 mmol/l, albumin 3.2 g/l, bilirubin 72 mmol/l, and prothrombin time was 65%. All patients had positive antimitochondrial and M2 antibodies, and the mean IgM level was 684 mg/dl. The diagnosis was confirmed by liver biopsy in 27 of 30 patients. To the best of our knowledge this represents the first report of primary biliary cirrhosis in the Jewish population in Israel. This retrospective survey raises the question whether the disease is indeed rare in Israel or, alternatively is underdiagnosed.
原发性胆汁性肝硬化(PBC)是一种相对罕见的自身免疫性疾病,可导致小叶间胆管上皮的破坏,中东地区尚未有相关报道。我们研究了30例转诊至耶路撒冷哈达萨医疗中心肝病科的PBC患者。根据传统标准,确诊为28例女性和2例男性患者。22例患者为阿什肯纳兹血统,8例为西班牙裔背景。诊断时平均血清碱性磷酸酶活性为911 IU/l,γ-谷氨酰转肽酶677 u/l,胆固醇73 mmol/l,白蛋白3.2 g/l,胆红素72 mmol/l,凝血酶原时间为65%。所有患者抗线粒体抗体和M2抗体均为阳性,平均IgM水平为684 mg/dl。30例患者中有27例经肝活检确诊。据我们所知,这是以色列犹太人群中原发性胆汁性肝硬化的首例报告。这项回顾性调查提出了一个问题,即该疾病在以色列是否真的罕见,或者是诊断不足。